AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2021
Jan 25, 2021
31580_dirs_2021-01-25_d70d6a5a-e88d-4dda-a117-46fa7669cfe4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK: 0001439222
Period of Report: 2021-01-16
Reporting Person: Miles Darrin (Chief Commercial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock | 5875 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock options (right to buy) | $110.91 | 2025-08-03 | Common stock (30000.0) | Direct | |
| Stock options (right to buy) | $39.76 | 2026-02-16 | Common stock (521.0) | Direct | |
| Stock options (right to buy) | $50.4 | 2027-02-21 | Common stock (12338.0) | Direct | |
| Stock options (right to buy) | $77.7 | 2028-02-16 | Common stock (11060.0) | Direct | |
| Stock options (right to buy) | $58.86 | 2029-02-22 | Common stock (8690.0) | Direct | |
| Stock options (right to buy) | $51.51 | 2030-02-14 | Common stock (35000.0) | Direct | |
| Restricted stock units | $ | Common stock (922.0) | Direct | ||
| Restricted stock units | $ | Common stock (1449.0) | Direct | ||
| Restricted stock units | $ | Common stock (26000.0) | Direct |
Footnotes
F1: This option was granted on August 3, 2015. The shares underlying this option are fully vested.
F2: This option was granted on February 16, 2016. The shares underlying this option are fully vested.
F3: This option was granted on February 21, 2017. The shares underlying this option vest as to 25% of the underlying shares on February 21, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F4: This option was granted on February 16, 2018. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F5: This option was granted on February 22, 2019. The shares underlying this option vest as to 25% of the underlying shares on February 22, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F6: This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F7: The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
F8: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F9: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
F10: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.